Pluristem Therapeutics Inc.

Pluristem Therapeutics Inc.

PSTI
Pluristem Therapeutics Inc.US flagNASDAQ Global Market
1.00
USD
-0.03
- -
40.85MMarket Cap

Pluristem Therapeutics Inc. (PSTI) Stock Split History

Learn about Pluristem Therapeutics Inc.'s most recent 1-for-10 basis stock split on July 25, 2019. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Pluristem Therapeutics Inc.'s most recent stock split

Split Date: 2019-07-25
Split Ratio: 1:10
Price Before Split: $0.45
Price After Split: $0.05

Developer API

Get PSTI split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/PSTI

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times fewer shares (a 1:10 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of Pluristem Therapeutics Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2019-07-251:10Yes$0.45$0.05
2007-11-261:200YesN/AN/A

About Pluristem Therapeutics Inc.

Company overview and industry information

Pluristem Therapeutics Inc. (PSTI) operates in the Biotechnology industry. The recent 1-for-10 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to Pluristem Therapeutics Inc. Summary

Last updated: 7/22/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.